SCHEDULE: Millennium Reduces Chemours Stake Below 5.1%

Millennium Management and affiliates report reducing their beneficial ownership in The Chemours Company to 5.1%, falling below the 5% threshold as of July 1, 2025.

Summary

• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed an Amendment No. 1 to Schedule 13G concerning their beneficial ownership of Common Stock in The Chemours Company.
• As of June 30, 2025, the aggregate amount beneficially owned by the reporting persons was 7,576,095 shares, representing 5.1% of the class.
• The reporting persons ceased to be beneficial owners of more than 5% of the outstanding Common Stock as of July 1, 2025.
• They hold shared voting power over 7,443,038 shares and shared dispositive power over 7,576,095 shares.

Sentiment

Score: 4

Explanation: The filing indicates a reduction in a significant institutional stake, which can be perceived as a negative signal, though it's a passive investment disclosure rather than an active divestment.

Negatives

• A significant institutional investor, Millennium Management and its affiliates, has reduced its beneficial ownership in The Chemours Company below the 5% threshold, which can be perceived as a negative signal by the market.

Future Outlook

No forward-looking statements or guidance regarding The Chemours Company's future performance or strategic direction are provided by the reporting persons in this filing.

Industry Context

This filing is a standard disclosure of a change in passive beneficial ownership by an institutional investor. It indicates a portfolio adjustment by Millennium Management, which may or may not reflect broader trends within the chemical industry or specific views on The Chemours Company's prospects beyond the decision to reduce their stake.

Stakeholder Impact

• Shareholders may interpret the reduction in stake by a major institutional investor as a signal of reduced confidence or a re-evaluation of investment priorities by that investor.

Key Dates

Recommendation

The filing indicates a significant institutional investor has reduced its stake in The Chemours Company below the 5% beneficial ownership threshold. While not a direct 'sell' signal, it suggests this particular investor is reallocating capital or reducing exposure, which warrants a 'hold' recommendation for existing investors to re-evaluate their position and for potential investors to exercise caution and conduct further due diligence.

Keywords

Chemours, Millennium Management, Schedule 13G, Beneficial Ownership, Institutional Investor, Chemicals